Latest Encision Inc (ECIA) Headlines Encision
Post# of 6
Encision Reports Third Quarter Fiscal Year 2014 Results
PR Newswire - Thu Jan 30, 9:19AM CST
Encision Inc. (OTC PINK: ECIA), a medical device company owning patented surgical technology that prevents stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2014 third quarter ended December 31, 2013.
Underarm Sweat Has Finally Met Its Match
PR Newswire - Tue Jan 28, 7:00AM CST
Board certified plastic surgeon Bryan G. Forley, MD, FACS, is the first plastic surgeon in New York to offer miraDry®, the innovative microwave technology that destroys underarm sweat glands in just two in-office sessions.
Encision Files 510(k) with FDA for AEM® Simplification Product
PR Newswire - Wed Jan 08, 6:00AM CST
Encision Inc. (ECIA K), a medical device company owning patented surgical technology that prevents stray electrosurgical burns in minimally invasive surgery, announced today that it has filed a premarket notification under Section 510(k) with the FDA of its intent to market what has previously been described as an AEM® simplification product, and is now called the EndoShield(TM) Burn Protection System ("EndoShield") (trademark applied for).
Encision Completes $2 Million Private Placement of Common Stock
PR Newswire - Wed Dec 18, 6:05AM CST
Encision Inc. (ECIA K), a medical device company owning patented surgical technology that prevents stray electrosurgical burns in minimally invasive surgery, announced today that it had completed a private placement of 2,463,125 shares of its common stock. The private placement, which represents 23% of the total number of shares outstanding, will raise, before costs, a total of approximately $2 million, which is to be used for general corporate purposes. The purchase price per share for the shares sold in the private placement was $0.80, representing a discount of approximately 12% based on a 20-day volume-weighted average price as of December 13, 2013. Additionally, the investors shall receive common stock purchase warrants. The warrants will be exercisable into 1,231,563 shares of the Company's common stock with an exercise price of $1.20 per share and a term of five years.
Encision Announces New President and CEO
PR Newswire - Wed Dec 18, 6:00AM CST
Encision Inc. (ECIA K), a medical device company owning patented surgical technology that prevents stray electrosurgical burns in minimally invasive surgery, today announced the appointment of Greg Trudel as its new President and CEO. A proven manager with over 25 years of experience in the surgical devices marketplace, Mr. Trudel will assume his new duties at Encision on December 23.
Encision Reports Second Quarter Fiscal Year 2014 Results
PR Newswire - Tue Nov 05, 6:00AM CST
Encision Inc. (ECIA K), a medical device company owning patented surgical technology that prevents stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2014 second quarter ended September 30, 2013.
Encision Announces Death of Chief Executive Officer Fred F. Perner
PR Newswire - Tue Sep 03, 6:15AM CDT
Encision Inc. (ECIA K) announced today that Fred F. Perner, 59, its Chief Executive Officer died unexpectedly on August 31 from an apparent heart attack.
OTC Daily Alert Stock Watch - Encision, Inc. (OTCQB: ECIA)
WorldStockWire - Tue Aug 27, 7:15PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
From Encision Inc.: New Medicare Penalties to Include Laparoscopic Complications
PR Newswire - Wed Aug 14, 6:00AM CDT
Encision Inc. (ECIA K). According to the Centers for Medicare and Medicaid Services ("CMS"), hospitals must now focus on reducing laparoscopic surgical complications, including lacerations and accidental punctures, or face penalties. Half of all unintended punctures and lacerations during laparoscopic monopolar surgery are caused by stray electrosurgical energy and half are caused by mechanical perforation. Stray energy burns alone have accounted for more than 16,500 preventable patient complications and 4,000 preventable patient deaths over a ten year period in the U.S. alone.[1]
Encision Names Patrick Pace, M.D. Chairman of the Board
PR Newswire - Mon Aug 12, 6:00AM CDT
Encision Inc. (ECIA K), a medical device company owning patented surgical technology that prevents stray electrosurgical burns in minimally invasive surgery, today announced that Patrick Pace, M.D, was named as Encision's non-executive Chairman of the Board. Dr. Pace has been a director of Encision's board since April 2012 and has served, and will continue to serve, on the nominating committee.
Encision Reports First Quarter Fiscal Year 2014 Results
PR Newswire - Wed Jul 31, 6:00AM CDT
Encision Inc. (ECIA K), a medical device company owning patented surgical technology that prevents stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2014 first quarter ended June 30, 2013.
Encision to Release First Quarter 2013 Results on July 31, 2013
PR Newswire - Mon Jul 29, 10:12AM CDT
Encision Inc. (ECIA K), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, today announced that they will release their first quarter 2013 results on Wednesday, July 31, 2013 before the market opens.
Encision Inc. and Virtual Ports Ltd. Announce Exclusive Distribution Agreement for Laparoscopic Surgery Devices
PR Newswire - Tue Apr 16, 12:22PM CDT
Encision Inc. ("Encision") (ECIA: PK) is pleased to announce an agreement with Virtual Ports Ltd. ("Virtual Ports") for exclusive distribution rights to the Virtual Ports' laparoscopic organ retraction products in the United States. Under the terms of the agreement, Encision will market and sell Virtual Ports' organ retraction products. Encision and Virtual Ports are both innovative companies that develop, manufacture and market medical devices that bring a higher level of performance to laparoscopic surgery. Encision's AEM® Technology eliminates stray energy burns during laparoscopic surgery. Virtual Ports' products provide secure laparoscopic organ retraction through its proprietary MicroAnchoring(TM) Technology.
Encision Launches Three New Products, Including the EM3 AEM® Monitor
PR Newswire - Wed Jan 30, 6:00AM CST
Encision Inc. (ECIA K), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, today announced that it is introducing three new products, including its EM3 AEM monitor.